Stay updated on Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial

Sign up to get notified when there's something new on the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. This is a minor metadata update and does not modify study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-01-14T01:49:33.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 text were removed.
    Difference
    0.1%
    Check dated 2025-12-23T17:12:06.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Minor site revision from v3.2.0 to v3.3.2 is shown; no study details or functionality are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:57:57.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Deleted the temporary notice about government funding lapses and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:51:42.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The study record now includes posted results for primary and secondary outcomes and updated results posting dates.
    Difference
    0.3%
    Check dated 2025-11-03T12:34:42.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    4%
    Check dated 2025-10-05T16:41:27.000Z thumbnail image

Stay in the know with updates to Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Balugrastim in Breast Cancer with Doxorubicin/Docetaxel Clinical Trial page.